Showing results (461-470 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|June 13, 2008
Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot studyRichard Elion, Edwin Dejesus, Michael Sension, et al.
HIV Clinical Trials|June 13, 2008
Determination of the underlying cause of death in three multicenter international HIV clinical trialsAlan R Lifson, , Waldo H Belloso, et al.
HIV Clinical Trials|April 8, 2017
Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, et al.
HIV Clinical Trials|January 28, 2017
Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACINGBruno Spire, Lella Nait-Ighil, Pascal Pugliese, et al.
HIV Clinical Trials|August 27, 2016
Increased homocysteine plasma level is associated with shortened prothrombin time in HIV-infected patientsBernardino Roca, Manuel Roca, Guillermo Girones
HIV Clinical Trials|June 21, 2014
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneQing Wang, Jim Young, Enos Bernasconi, et al.
HIV Clinical Trials|March 18, 2015
Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysisSheng-Li Li, Peng Xu, Lei Zhang, et al.
HIV Clinical Trials|March 18, 2015
96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjectsDanielle P Porter, Rima Kulkarni, Todd Fralich, et al.
HIV Clinical Trials|April 16, 2015
Cerebral function in perinatally HIV-infected young adults and their HIV-uninfected sibling controlsJane Ashby, Caroline Foster, Lucy Garvey, et al.
HIV Clinical Trials|April 16, 2015
Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in SpainVicente Estrada, José Ignacio Bernardino, Mar Masiá, et al.
Pageof 68